-
J.P. Morgan Resumes Coverage of Endo Pharmaceuticals with Overweight and PT of $50
Tuesday, June 21, 2011 - 8:33am | 87J.P. Morgan resumed coverage of Endo Pharmaceuticals (NASDAQ: ENDP) with an Overweight rating and a price target of $50. In a research report published today, J.P. Morgan states, "Due to the completion of J.P. Morgan's involvement in the transaction announced on April 11, 2011, we...
-
News Summary for June 21, 2011
Tuesday, June 21, 2011 - 8:06am | 355This is your Benzinga news summary and traders' outlook for Tuesday, June 21, 2011, covering headlines from overnight and Tuesday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading higher as the U.S. dollar is slightly lower this morning on optimism of a...
-
Pfizer's Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
Tuesday, June 21, 2011 - 7:31am | 137Pfizer Inc. (NYSE: PFE) announced today that top-line results for Lyrica Study A0081107 – Central Neuropathic Pain Following Spinal Cord Injury – demonstrated that the study met its primary endpoint: positive efficacy in reducing Central Neuropathic Pain following Spinal Cord Injury with Lyrica (...
-
A Peek Into The Market Before The Trading Starts
Tuesday, June 21, 2011 - 7:25am | 401Pre-open movers US stock futures are higher this morning, ahead of a confidence vote in the Greek parliament later in the day. Futures on the Dow Jones Industrial Average surged 46 points to 12,059.00 and futures on the S&P 500 stock index rose 5.20 points to 1,279.00. Nasdaq 100 futures gained...
-
Hi-Tech Pharmacal Receives Final Approval for Levofloxacin Oral Solution
Tuesday, June 21, 2011 - 7:03am | 170Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for levofloxacin oral solution 25mg/mL, the generic for McNeil Pharmaceutical's Levaquin® oral solution which...
-
Depomed Files Patent Infringement Lawsuit Against Sun Pharmaceutical Industries
Tuesday, June 21, 2011 - 7:02am | 57Depomed, Inc. (Nasdaq: DEPO) today announced that it has filed a lawsuit in the United States District Court for the District of New Jersey against Sun Pharmaceutical Industries, for infringement of the patents listed in the Orange Book for Depomed's 500 mg and 1000 mg Glumetza® (metformin...
-
Spectrum Pharmaceuticals Has Ample Supplies of FUSILEV to Meet the Growing Demand of Colorectal Cancer Patients in the U.S.
Tuesday, June 21, 2011 - 7:00am | 84Spectrum Pharmaceuticals (Nasdaq: SPPI) announced today that during the second quarter the Company has worked closely with the U.S. Food & Drug Administration on securing multiple sources of U.S. manufacturing for the Company's anti-cancer drug, FUSILEV, approved on April 29, 2011 for use in...
-
Eli Lilly and Amylin Pharmaceuticals Announces BYDUREON Receives Marketing Authorization in Europe
Tuesday, June 21, 2011 - 7:00am | 106Eli Lilly and Company (NYSE: LLY), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes, Inc. (Nasdaq: ALKS), announced today that the European Commission has granted marketing authorization to BYDUREON. BYDUREON, a glucagon-like peptide-1 receptor agonist, is the first once-...
-
Greece is the Word 06-20-2011
Monday, June 20, 2011 - 7:53pm | 728Cusick's Corner The market held into the After Hours and now overnight and into the early morning, all eyes will be on the Vote in Greece. The wild card here is if the Greeks do not vote confidence in the government and hold up the austerity, then default is a hotter button issue again for the EU...
-
Lilly Declares Third-Quarter 2011 Dividend of $0.49/Share
Monday, June 20, 2011 - 4:07pm | 51The board of directors of Eli Lilly and Company (NYSE: LLY) today declared a dividend for the third quarter of 2011 of $0.49 a share on outstanding common stock. The dividend is payable September 9, 2011 to shareholders of record at the close of business on August 15, 2011.
-
Watson Confirms AVODART Patent Challenge
Monday, June 20, 2011 - 4:01pm | 151Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Dutasteride Capsules, 0.5 mg. Watson's Dutasteride Capsules product is...
-
Higher Beta Leading the Way 06-20-2011
Monday, June 20, 2011 - 2:55pm | 972Cusick's Corner The market is experiencing a nice oversold squeeze to the upside which is the type of action that one can expect now, it's choppy trading while Greece and the Fed work out austerity plans and their next steps, if any (for the Fed there may be additional QE, Quantitative Easing). I...
-
Biotech/Pharma Stocks; Take A New Approach to Cancer
Monday, June 20, 2011 - 1:40pm | 1617Point Roberts, WA- June 17, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, reports on advances in Cancer Immunotherapy featuring Aethlon Medical (OTCBB: AEMD), Bristol-Myers Squibb Company (NYSE: BMY), Dendreon Corporation...
-
3 High Dividend Stocks The Smart Money Is Buying
Monday, June 20, 2011 - 11:59am | 441In times of uncertainty, investors look to high-dividend paying stocks for some sort of normalcy. Every investor looks for dividends to juice yields and returns, as dividends are an important source of income for many, especially retirees. We also want to be playing the same game the "smart money...
-
Adolor up Over 3% on Positive Seeking Alpha Article
Monday, June 20, 2011 - 10:50am | 58Adolor (NASDAQ: ADLR) is up over 3% on the session on a positive Seeking Alpha article. Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. The Seeking Alpha article can be found here.